Clinical Trial Update: AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia [Phase 1]

View source ↗

Summary

This document reports a completed Phase 1 trial of AT9283 in young patients with relapsed or refractory acute leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• AT9283 (AT9283)

Snippet

Sponsor: Cancer Research UK | Conditions: Leukemia | Phase 1 | Status: COMPLETED